Fig. 6From: The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signalingThe soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via AHR and TSPO signaling. Spared nerve ingury (SNI) was used for the rodent model of pain-depression comorbidity. sEH inhibitor exerted antidepressant-like and analgesic effects in two ways: (1) inhibiting AHR signaling to function as antidepressant; and (2) improving depressive-like and hyperalgesic behaviors by increasing the TSPO protein levelsBack to article page